NASDAQ:AGPU Predictive Oncology (AGPU) Stock Price, News & Analysis $5.43 +0.23 (+4.42%) Closing price 04:00 PM EasternExtended Trading$5.40 -0.03 (-0.55%) As of 06:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsSEC FilingsTrendsBuy This Stock About Predictive Oncology Stock (NASDAQ:AGPU) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Predictive Oncology alerts:Sign Up Key Stats Today's Range$4.90▼$5.5050-Day Range$1.41▼$8.7552-Week Range$1.03▼$32.10Volume365,223 shsAverage Volume2.52 million shsMarket Capitalization$30.08 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Predictive Oncology (NASDAQ: AGPU) is a biotechnology company focused on oncology-related research and product development that combines laboratory science with data analytics. The company positions itself to support precision medicine by applying computational methods and laboratory testing to better understand tumor biology and to accelerate the identification and development of oncology therapeutics and diagnostics. Its activities include laboratory-based testing and analytic services intended to inform drug discovery and development, biomarker identification, and patient stratification efforts. Predictive Oncology offers services and tools designed to help biopharmaceutical companies and research organizations evaluate therapeutic candidates and develop companion diagnostic strategies, leveraging a mix of experimental assays and data-driven analysis to generate actionable insights for oncology programs. As a publicly traded company, Predictive Oncology works with commercial and research partners in the life sciences ecosystem. Publicly available, detailed historical background and current leadership information were limited at the time of this summary; readers seeking executive biographies, recent corporate developments or a full corporate history should consult the company’s regulatory filings and investor relations materials for the most current and authoritative information.AI Generated. May Contain Errors. Read More Predictive Oncology Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks7th Percentile Overall ScoreAGPU MarketRank™: Predictive Oncology scored higher than 7% of companies evaluated by MarketBeat, and ranked 50th out of 59 stocks in the manufacturing sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingPredictive Oncology has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoveragePredictive Oncology has only been the subject of 1 research reports in the past 90 days.Read more about Predictive Oncology's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Predictive Oncology is -0.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Predictive Oncology is -0.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPredictive Oncology has a P/B Ratio of 0.46. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for AGPU. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPredictive Oncology does not currently pay a dividend.Dividend GrowthPredictive Oncology does not have a long track record of dividend growth. News and Social Media3.2 / 5News Sentiment0.13 News SentimentPredictive Oncology has a news sentiment score of 0.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Manufacturing companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Predictive Oncology this week, compared to 2 articles on an average week.Search Interest29 people have searched for AGPU on MarketBeat in the last 30 days. This is an increase of 263% compared to the previous 30 days.MarketBeat Follows1 people have added Predictive Oncology to their MarketBeat watchlist in the last 30 days. Company Ownership0.2 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Predictive Oncology insiders have not sold or bought any company stock.Percentage Held by Insiders1.21% of the stock of Predictive Oncology is held by insiders.Percentage Held by Institutions9.04% of the stock of Predictive Oncology is held by institutions.Read more about Predictive Oncology's insider trading history. Receive AGPU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Predictive Oncology and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AGPU Stock News HeadlinesAxe Compute Inc. (NASDAQ: AGPU) CEO Chris Miglino to Appear on Schwab Network May 4 and Cheddar May 6May 4 at 8:30 AM | globenewswire.comCritical Review: Predictive Oncology (NASDAQ:AGPU) versus MiniMed Group (NASDAQ:MMED)May 4 at 4:51 AM | americanbankingnews.comYou’re Being LIED To About The Iran WarThe mainstream explanation for the Iran airstrikes may not be the full story. Addison Wiggin, Founder of Grey Swan Investment Fraternity, says there's a deeper motive behind the bombing campaign that most coverage is ignoring. If you're making investment decisions based on what you're hearing in the news, Wiggin argues you could be working with an incomplete picture.May 5 at 1:00 AM | Banyan Hill Publishing (Ad)Analyzing Bioventus (NASDAQ:BVS) & Predictive Oncology (NASDAQ:AGPU)May 3 at 3:58 AM | americanbankingnews.comAxe Compute to Present at the Market Movers Investor Summit and the D. Boral Capital 2026 Global ConferenceApril 28, 2026 | globenewswire.comAxe Compute Stock Rockets Higher On $260 Million GPU ContractApril 22, 2026 | benzinga.comAxe Compute Names Kyle Okamoto President, Adding Deep Infrastructure Systems Expertise to Executive TeamApril 6, 2026 | globenewswire.comAxe Compute Inc. (AGPU) Q4 2025 Earnings Call Prepared Remarks TranscriptApril 1, 2026 | seekingalpha.comSee More Headlines AGPU Stock Analysis - Frequently Asked Questions How have AGPU shares performed this year? Predictive Oncology's stock was trading at $5.04 on January 1st, 2026. Since then, AGPU shares have increased by 7.7% and is now trading at $5.43. How were Predictive Oncology's earnings last quarter? Predictive Oncology Inc. (NASDAQ:AGPU) issued its quarterly earnings results on Tuesday, March, 31st. The company reported $122.75 EPS for the quarter. The firm had revenue of $0.01 million for the quarter. How do I buy shares of Predictive Oncology? Shares of AGPU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings3/31/2026Today5/05/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 AGPU's financial health is in the Green zone, according to TradeSmith. AGPU has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorManufacturing Industry Surgical, Medical, And Dental Instruments And Supplies Sub-IndustryMedical Equipment Current SymbolNASDAQ:AGPU CIK1446159 WebN/A Phone(651) 389-4800FaxN/AEmployees30Year FoundedN/AProfitability EPS (Trailing Twelve Months)($12.62) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$233.10 million Net Margins-185,476.72% Pretax Margin-185,860.92% Return on EquityN/A Return on Assets-970.41% Debt Debt-to-Equity RatioN/A Current Ratio10.02 Quick Ratio10.02 Sales & Book Value Annual Sales$125.28 thousand Price / Sales240.07 Cash FlowN/A Price / Cash FlowN/A Book Value$11.69 per share Price / Book0.46Miscellaneous Outstanding Shares5,539,000Free Float5,472,000Market Cap$30.08 million OptionableN/A Beta3.45 7 Stocks to Buy Before SpaceX Goes PublicSpaceX has quietly filed to go public later this year. Ahead of what's expected to be the largest IPO of all time, there are seven space stocks that you can buy today that are positioned to benefit from accelerating space commercialization in 2026. These seven companies are shaping the next phase of the space economy—from launch leaders and satellite networks to data, defense, and in-space infrastructure.Get This Free Report This page (NASDAQ:AGPU) was last updated on 5/5/2026 by MarketBeat.com Staff. From Our PartnersIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredThe $1.75T "Backdoor" ticker (NOT Starlink)When the SpaceX IPO launches, most investors will already be too late. The real opportunity isn't the IPO itse...Behind the Markets | SponsoredSell 99% of Your Stocks, Do THIS Instead…Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...The Oxford Club | SponsoredTrade this between 9:30 and 10:45 am ESTThe first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...Base Camp Trading | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredElon Unveils AI Passive Income Stream for Millions of AmericansDuring Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Predictive Oncology Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Predictive Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
